Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100051438Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial in sleep disorder comparing Dexmedetomidine infusion with Saline infusion (placebo control) (2 arms). Primary endpoints: percentage of N1 sleep, percentage of N2 sleep and 2 more. Planned start Oct 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100051438.